Immunoassays Market Research Reports & Industry Analysis
An immunoassay is one of the most effectual analytical tests performed due to its specificity, sensitivity and versatility. To test the concentration of a substance within a solution, immunoassay tests use specific antibodies that will react with antigens in the solution. Monoclonal antibodies provide accurate test results and are the most common antibodies used in immunoassay testing due to their ability to bind to one site of any particular molecule. To get an accurate result, the specific antibody must have a high affinity to the antigen being tested for. The number of antigens and antibodies present in the tested solution is measured. This measurement tells how much of the analyte is located within the sample and how concentrated it is.
One of the most widely used immunoassay applications for the detection of infectious disease is the enzyme-linked immunosorbant assay (ELISA). Because of its high sensitivity, the ELISA was the first screening test widely used for HIV.
Immunoassays are significant tests that perform an array of functions in conventional medicine. While it is used primarily to test for things such as HIV in the body, the test can also be used to discover new ways to test for other diseases and conditions that don’t have a direct scientific diagnostic method.
Immunoassays Industry Research & Market Reports
-
Dengue Testing Market Report by Test Type (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, and Others), End User (Hospitals, Diagnostic Centers, and Others), and Region 2025-2033
... The market is primarily driven by the increasing dengue fever prevalence worldwide, advancements in diagnostic technologies, rising public health awareness, and government initiatives and funding in endemic regions across the globe. Dengue, also known as ... Read More
-
Renal Biomarkers Market Report by Biomarker Type (Functional Biomarker, Up-regulated Protein, and Others), Diagnostic Technique (Enzyme-linked Immunosorbent Assay (ELISA), Particle-enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LC-MS)), End User (Hospital, Diagnostic Laboratory, and Others), and Region 2025-2033
... The increasing public health concerns and its main risk factors, including hypertension, diabetes, and heart diseases, are bolstering the market. Renal biomarkers are cells, proteins, lipids, microRNAs, genes, metabolites, or proteomic patterns present on a ... Read More
-
Global in Vitro Diagnostics Contract Manufacturing Market 2025-2029
... period. The report on the in vitro diagnostics (IVD) contract manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The ... Read More
-
Global Multiplexed Diagnostics Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Cell Based Assays Market by Offering (Consumables (Reagents, Assay Kits, Cell Lines, Microplates, Probes, Labels), Instruments & Software), Technology (Flow Cytometry, HTS), Application (Drug Discovery (Toxicity, PK/PD Studies)) - Global Forecast to 2030
... growth can be largely attributed to the increasing demand for drug discovery and the rising need for cell-based assays in this area. Furthermore, higher research & development investments from the pharmaceutical and biotechnology industries are ... Read More
-
Immunochemistry Diagnostic Devices And Equipment Global Market Report 2025
... diagnostic devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Medical Diagnostics, Reagents, Assays and Test Kits Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325413
... forecasts that will save countless hours of research. Key Findings: Medical Diagnostics, Reagents, Assays and Test Kits Manufacturing Industry (U.S.) to reach $30,177,992,896 by 2031. Medical Diagnostics, Reagents, Assays and Test Kits Manufacturing Industry (U.S.), ... Read More
-
Hemoglobin A1C (HbA1C) Testing
... 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Ion-Exchange High Performance Liquid Chromatography (HPLC), one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach ... Read More
-
Research ELISA (Enzyme-Linked Immunosorbent Assay)
... Million by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. ELISA Kits, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$478.6 Million ... Read More
-
High Content Screening (HCS)
... 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$1.0 Billion by the end ... Read More
-
Reporter Gene Assays
... at a CAGR of 6.5% over the analysis period 2024-2030. Luciferase Assays, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$4.6 Billion by the end of ... Read More
-
Immunoassay Systems
... CAGR of 3.6% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$19.4 Billion by the end of the ... Read More
-
Mycotoxin Testing
... CAGR of 5.9% over the analysis period 2024-2030. Spectroscopy- & Chromatography-Based, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$1.6 Billion by the end of the ... Read More
-
Radioimmunoassays
... 3.2% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$458.7 Million by the end of the analysis period. ... Read More
-
Multiplex Detection Immunoassays
... at a CAGR of 3.4% over the analysis period 2024-2030. Protein-Based Multiplex Technique, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$2.4 Billion by the end ... Read More
-
Automated Liquid Handling Systems
... 2030, growing at a CAGR of 10.8% over the analysis period 2024-2030. Automated Liquid Handling Workstations, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$1.6 Billion ... Read More
-
Cell Viability Assays
... at a CAGR of 7.1% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$5.3 Billion by the end of the ... Read More
-
Immunofluorescence Assays
... CAGR of 4.4% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$3.8 Billion by the end of the analysis period. ... Read More
-
Zika Virus Testing
... at a CAGR of 5.8% over the analysis period 2024-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$192.4 Million by the end of ... Read More
-
Veterinary Rapid Test Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Multiplex PCR Assays Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Automated Liquid Handling (ALH) Technologies
... Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2024-2030. Automated Liquid Handling Workstations, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach ... Read More
-
In Vitro Toxicology Testing
... 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. Cell Culture Technology, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$11.2 Billion by ... Read More
-
C-Reactive Protein Testing
... at a CAGR of 1.7% over the analysis period 2024-2030. Cardiovascular Diseases, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.0 Billion by the end of ... Read More
-
In Vitro Diagnostics
... at a CAGR of 3.4% over the analysis period 2024-2030. IVD Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$86.3 Billion by the ... Read More
Research Assistance
